TITLE

Efficient derivation of osteoprogenitor cells from induced pluripotent stem cells for bone regeneration

AUTHOR(S)
Dogaki, Yoshihiro; Lee, Sang; Niikura, Takahiro; Iwakura, Takashi; Okumachi, Etsuko; Waki, Takahiro; Kakutani, Kenichiro; Nishida, Kotaro; Kuroda, Ryosuke; Kurosaka, Masahiro
PUB. DATE
September 2014
SOURCE
International Orthopaedics;Sep2014, Vol. 38 Issue 9, p1779
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: There has been great interest in the use of induced pluripotent stem cells (iPSCs) in bone regenerative strategies. To generate osteoprogenitor cells from iPSCs, the most widely used protocol relies on an intermediate using embryoid body (EB) formation. We hypothesized that an osteoprogenitor cell population could be efficiently generated from iPSCs by employing a 'direct-plating method' without the EB formation step. Methods: Murine iPSC colonies were dissociated with trypsin-EDTA, and obtained single cells were cultured on gelatin-coated plates in MSC medium and FGF-2. Adherent homogeneous fibroblast-like cells obtained by this direct-plating technique were termed as direct-plated cells (DPCs). Expression levels of Oct-3/4 mRNA were analysed by real-time PCR. DPCs were evaluated for cell-surface protein expression using flow cytometry. After osteogenic induction, osteogenic differentiation ability of DPCs was evaluated. Results: The expression level of Oct-3/4 in DPCs was significantly down-regulated compared to that observed in iPSCs, suggesting that the cells lost pluripotency. Flow cytometry analysis revealed that DPCs exhibited cell-surface antigens similar to those of bone marrow stromal cells. Furthermore, the cells proved to have a high osteogenic differentiation capacity, which was confirmed by the significant increase in alkaline phosphatase activity, the expression levels of osteogenic genes, and calcium mineralization after 14-day osteogenic induction. Conclusions: These findings indicate that our novel direct-plating method provides a clinically applicable, simple, and labour-efficient system for generating large numbers of homogeneous iPSC-derived osteoprogenitor cells for bone regeneration.
ACCESSION #
97809864

 

Related Articles

  • Generation of iPSCs by Nonintegrative RNA-Based Reprogramming Techniques: Benefits of Self-Replicating RNA versus Synthetic mRNA. Steinle, Heidrun; Weber, Marbod; Behring, Andreas; Mau-Holzmann, Ulrike; Schlensak, Christian; Wendel, Hans Peter; Avci-Adali, Meltem // Stem Cells International;6/19/2019, p1 

    The reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) is gaining in importance in the fields of regenerative medicine, tissue engineering, and disease modeling. Patient-specific iPSCs have as an unlimited cell source a tremendous potential for generating various types of...

  • Generation of iPSCs as a Pooled Culture Using Magnetic Activated Cell Sorting of Newly Reprogrammed Cells. Yang, Wenli; Liu, Ying; Slovik, Katherine J.; Wu, Joseph C.; Duncan, Stephen A.; Rader, Daniel J.; Morrisey, Edward E. // PLoS ONE;8/17/2015, Vol. 10 Issue 8, p1 

    Although significant advancement has been made in the induced pluripotent stem cell (iPSC) field, current methods for iPSC derivation are labor intensive and costly. These methods involve manual selection, expansion, and characterization of multiple clones for each reprogrammed cell sample and...

  • Embryonic stem cell potency fluctuates with endogenous retrovirus activity. Macfarlan, Todd S.; Gifford, Wesley D.; Driscoll, Shawn; Lettieri, Karen; Rowe, Helen M.; Bonanomi, Dario; Firth, Amy; Singer, Oded; Trono, Didier; Pfaff, Samuel L. // Nature;7/5/2012, Vol. 487 Issue 7405, p57 

    Embryonic stem (ES) cells are derived from blastocyst-stage embryos and are thought to be functionally equivalent to the inner cell mass, which lacks the ability to produce all extraembryonic tissues. Here we identify a rare transient cell population within mouse ES and induced pluripotent stem...

  • Identification and Purification of Human Induced Pluripotent Stem Cell-Derived Atrial-Like Cardiomyocytes Based on Sarcolipin Expression. Josowitz, Rebecca; Lu, Jia; Falce, Christine; D’Souza, Sunita L.; Wu, Meng; Cohen, Ninette; Dubois, Nicole C.; Zhao, Yong; Sobie, Eric A.; Fishman, Glenn I.; Gelb, Bruce D. // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    The use of human stem cell-derived cardiomyocytes to study atrial biology and disease has been restricted by the lack of a reliable method for stem cell-derived atrial cell labeling and purification. The goal of this study was to generate an atrial-specific reporter construct to identify and...

  • Tissue engineering (IBMS/JSBMR joint meeting 2013). Tsumaki, Noriyuki // IBMS BoneKEy;Aug2013, Vol. 10 Issue 8, p397 

    Information about several papers discussed at the International Bone and Mineral Society and the Japanese Society for Bone and Mineral Research (IBMS/JSBMR) meeting held in Kobe Island, Japan on May 28-June 1, 2013 is presented. Topics include the induced pluripotent stem (iPS) cells for bone...

  • Induced pluripotent stem cells: the new patient? Bellin, Milena; Marchetto, Maria C.; Gage, Fred H.; Mummery, Christine L. // Nature Reviews Molecular Cell Biology;Nov2012, Vol. 13 Issue 11, p713 

    Worldwide increases in life expectancy have been paralleled by a greater prevalence of chronic and age-associated disorders, particularly of the cardiovascular, neural and metabolic systems. This has not been met by commensurate development of new drugs and therapies, which is in part owing to...

  • Research Highlights.  // Molecular Therapy;Jul2012, Vol. 20 Issue 7, p1293 

    The article presents several researches concerning molecular therapy. It says that a study published in the journal "Cell Stem Cell" focuses on the development of a rapidly dividing skeletal myogenic progenitor cell population from induced pluripotent stem (iPS) cells. It states that a study...

  • Safety of induced stem cells gets a boost. Baker, Monya // Nature;1/10/2013, Vol. 493 Issue 7431, p145 

    The article focuses on a study conducted by researcher Masumi Abe and his team regarding induced pluripotent stem (iPS) cells derived from mice, which found that these cells perform worse than embryonic stem (ES) cells. Researcher Yang Xu claims that all concerns about the immune response...

  • CD166pos Subpopulation From Differentiated Human ES and iPS Cells Support Repair of Acute Lung Injury. Soh, Boon Seng; Zheng, Dahai; Li Yeo, Julie Su; Yang, Henry He; Ng, Shi Yan; Wong, Lan Hiong; Zhang, Wencai; Li, Pin; Nichane, Massimo; Asmat, Atasha; Wong, Poo Sing; Wong, Peng Cheang; Su, Lin Lin; Mantalaris, Sakis A; Lu, Jia; Xian, Wa; McKeon, Frank; Chen, Jianzhu; Lim, Elaine Hsuen; Lim, Bing // Molecular Therapy;Dec2012, Vol. 20 Issue 12, p2335 

    Previous efforts to derive lung progenitor cells from human embryonic stem (hES) cells using embryoid body formation or stromal feeder cocultures had been limited by low efficiencies. Here, we report a step-wise differentiation method to drive both hES and induced pluripotent stem (iPS) cells...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics